Effectiveness of inpatient treatment on quality of life and clinical disease severity in atopic dermatitis and psoriasis vulgaris - A prospective study

被引:18
作者
Schmitt, Jochen [1 ]
Heese, Elisabeth [1 ]
Wozel, Gottfried [1 ]
Meurer, Michael [1 ]
机构
[1] Tech Univ Dresden, Hosp Carl Gustav Carus, Dept Dermatol, DE-01307 Dresden, Germany
关键词
atopic dermatitis; Dermatology Life Quality Index; disease severity; Eczema Area and Severity Index; psoriasis vulgaris; Psoriasis Area and Severity Index;
D O I
10.1159/000096916
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Financial constraints challenge evidence of the effectiveness of dermatological inpatient management. Objective: To evaluate the effectiveness of hospitalization in atopic dermatitis and psoriasis regarding initial and sustained benefits. Methods: Prospective study on adults with psoriasis vulgaris (n = 22) and atopic dermatitis ( n = 14). At admission, discharge, and 3 months after discharge, validated outcomes of objective and subjective disease severity were assessed by trained investigators. Results: Hospitalization resulted in substantial benefit in quality of life and clinical disease severity. Looking at mean scores, the observed benefit appeared stable until 3-month follow-up. The analysis of individual patient data revealed significant changes in disease severity between discharge and 3-month follow-up with some patients relapsing, others further improving. Reasons for hospitalization and treatment performed were not related to sustained benefit. Conclusions: In psoriasis vulgaris and atopic dermatitis, hospitalization effectively improved quality of life and clinical disease severity. Further research should focus on prognostic factors for sustained improvement. Copyright (c) 2007 S. Karger AG, Basel.
引用
收藏
页码:68 / 76
页数:9
相关论文
共 32 条
  • [1] [Anonymous], 2002, Br J Dermatol
  • [2] Hospitalization for severe skin disease improves quality of life in the United Kingdom and the United States: A comparative study
    Ayyalaraju, RS
    Finlay, AY
    Dykes, PJ
    Trent, JT
    Kirsner, RS
    Kerdel, FA
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003, 49 (02) : 249 - 254
  • [3] Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1550 patients from the pimecrolimus cream 1% randomized controlled clinical trials programme
    Barbier, N
    Paul, C
    Luger, T
    Allen, R
    De Prost, Y
    Papp, K
    Eichenfield, LF
    Cherill, R
    Hanifin, J
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2004, 150 (01) : 96 - 102
  • [4] PS power and sample size program available for free on the Internet
    Dupont, WD
    Plummer, WD
    [J]. CONTROLLED CLINICAL TRIALS, 1997, 18 (03): : 274 - 274
  • [5] Ellis Charles N, 2003, J Manag Care Pharm, V9, P278
  • [6] DERMATOLOGY LIFE QUALITY INDEX (DLQI) - A SIMPLE PRACTICAL MEASURE FOR ROUTINE CLINICAL USE
    FINLAY, AY
    KHAN, GK
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1994, 19 (03) : 210 - 216
  • [7] FINLAY AY, 1995, BRIT J DERMATOL, V132, P236
  • [8] Finlay AY, 2001, ARCH DERMATOL, V137, P352
  • [9] Quality of life in atopic dermatitis - Discussion
    Leung, DYM
    Finlay, AY
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2001, 45 (01) : S66 - S66
  • [10] SEVERE PSORIASIS - ORAL THERAPY WITH A NEW RETINOID
    FREDRIKSSON, T
    PETTERSSON, U
    [J]. DERMATOLOGICA, 1978, 157 (04): : 238 - 244